经动脉化疗栓塞术（TACE）治疗的“6分和12分评分”：它真的对我们有帮助吗？ - Suppr

Suppr

超能文献

The "six-and-twelve score" for TACE treatment: Does it really help us?

作者信息

Bourlière Marc, Pénaranda Guillaume, Adhoute Xavier, Bronowicki Jean-Pierre

机构信息

Department of Gastroenterology and Hepatology, Hôpital Saint-Joseph Marseille, France.

AlphaBio Laboratory Marseille, France.

出版信息

J Hepatol. 2019 Nov;71(5):1051-1052. doi: 10.1016/j.jhep.2019.06.014. Epub 2019 Sep 9.

DOI:10.1016/j.jhep.2019.06.014

PMID:31515044

Abstract

摘要

相似文献

The "six-and-twelve score" for TACE treatment: Does it really help us?

J Hepatol. 2019 Nov;71(5):1051-1052. doi: 10.1016/j.jhep.2019.06.014. Epub 2019 Sep 9.

Reply to: "The "six-and-twelve score" for TACE treatment: Does it really help us?".

J Hepatol. 2019 Nov;71(5):1053-1054. doi: 10.1016/j.jhep.2019.07.009. Epub 2019 Sep 26.

Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.

Oncologist. 2019 Apr;24(4):513-520. doi: 10.1634/theoncologist.2018-0305. Epub 2018 Dec 14.

Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.

J Gastroenterol Hepatol. 2016 Feb;31(2):442-9. doi: 10.1111/jgh.13077.

Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma.

Cardiovasc Intervent Radiol. 2019 Feb;42(2):230-238. doi: 10.1007/s00270-018-2118-6. Epub 2018 Nov 28.

The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study.

Gastroenterol Hepatol. 2017 Oct;40(8):515-524. doi: 10.1016/j.gastrohep.2017.05.009. Epub 2017 Jul 1.

Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.

Cardiovasc Intervent Radiol. 2017 Nov;40(11):1748-1755. doi: 10.1007/s00270-017-1736-8. Epub 2017 Jul 5.

How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma.

J Hepatol. 2014 Dec;61(6):1287-96. doi: 10.1016/j.jhep.2014.07.002. Epub 2014 Jul 10.

Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis.

Surg Oncol. 2019 Mar;28:228-235. doi: 10.1016/j.suronc.2019.01.006. Epub 2019 Jan 29.

Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.

Cardiovasc Intervent Radiol. 2016 Mar;39(3):417-25. doi: 10.1007/s00270-015-1194-0. Epub 2015 Aug 6.

引用本文的文献

Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score.

BMC Cancer. 2024 Mar 6;24(1):306. doi: 10.1186/s12885-024-12049-4.

Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis.

World J Methodol. 2023 Sep 20;13(4):345-358. doi: 10.5662/wjm.v13.i4.345.

The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization.

Front Oncol. 2022 Sep 29;12:1005571. doi: 10.3389/fonc.2022.1005571. eCollection 2022.

Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations.

Cancers (Basel). 2022 May 17;14(10):2469. doi: 10.3390/cancers14102469.

Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems.

Front Oncol. 2022 Feb 23;12:850454. doi: 10.3389/fonc.2022.850454. eCollection 2022.

Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver Function.

Cancers (Basel). 2021 Aug 5;13(16):3961. doi: 10.3390/cancers13163961.

Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide.

J Hepatocell Carcinoma. 2021 May 13;8:403-419. doi: 10.2147/JHC.S285735. eCollection 2021.

"Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort.

World J Hepatol. 2020 Aug 27;12(8):525-532. doi: 10.4254/wjh.v12.i8.525.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验